The clinical implications of adrenal failure following long-term glucocorticoid treatment warrant additional studies to determine whether modulation of osteocalcin levels restores endogenous adrenocortical function and, if so, might be developed to treat adrenal insufficiency. The gene discussed is BGLAP; the disease is Adrenal insufficiency.